Literature DB >> 9003176

Preferences of husbands and wives for prostate cancer screening.

R J Volk1, S B Cantor, S J Spann, A R Cass, M P Cardenas, M M Warren.   

Abstract

The benefits of screening for prostate cancer are uncertain. Outcomes of treatment are particularly important to couples because they challenge the most intimate aspects of a couple's relationship. This study used clinical decision analysis to explore the preferences of 10 couples for prostate cancer screening. The decision-analytic model found that 7 of 10 husbands preferred the no screening strategy, while 9 of 10 wives preferred screening for their husbands. Wives associated little burden with complications of treatment, preferring to maximize their husbands' quantity of life regardless of complications. The issue of who is the decision maker is paramount in the case of prostate cancer screening. Optimal screening strategies may differ for husbands and wives. Guidelines for prostate cancer screening and management should consider assessing preferences on an individual couple basis.

Entities:  

Keywords:  American Cancer Society; American Urological Society; Empirical Approach; Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  1997        PMID: 9003176     DOI: 10.1001/archfami.6.1.72

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  9 in total

1.  Cost-utility analysis: use QALYs only with great caution.

Authors:  Maurice McGregor
Journal:  CMAJ       Date:  2003-02-18       Impact factor: 8.262

2.  Concordance of couples' prostate cancer screening recommendations from a decision analysis.

Authors:  Scott B Cantor; Robert J Volk; Murray D Krahn; Alvah R Cass; Jawaria Gilani; Susan C Weller; Stephen J Spann
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

3.  QALYs: are they helpful to decision makers?

Authors:  Maurice McGregor; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Validity and feasibility of the use of condition-specific outcome measures in economic evaluation.

Authors:  Elly A Stolk; Jan J V Busschbach
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

5.  Use of forecasted assessment of quality of life to validate time-trade-off utilities and a prostate cancer screening decision-analytic model.

Authors:  Scott B Cantor; Ashish A Deshmukh; Murray D Krahn; Robert J Volk
Journal:  Health Expect       Date:  2013-10-23       Impact factor: 3.377

6.  The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Authors:  Floyd J Fowler; Michael J Barry; Beth Walker-Corkery; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Mary McNaughton-Collins
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

7.  Awareness and use of the prostate-specific antigen test among African-American men.

Authors:  Louie E Ross; Robert J Uhler; Kymber N Williams
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 8.  Men's and carers' experiences of care for prostate cancer: a narrative literature review.

Authors:  Paul Sinfield; Richard Baker; Janette Camosso-Stefinovic; Andrew M Colman; Carolyn Tarrant; John K Mellon; William Steward; Roger Kockelbergh; Shona Agarwal
Journal:  Health Expect       Date:  2009-09       Impact factor: 3.377

9.  Preferences of husbands and wives for outcomes of prostate cancer screening and treatment.

Authors:  Robert J Volk; Scott B Cantor; Alvah R Cass; Stephen J Spann; Susan C Weller; Murray D Krahn
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.